ACHIEVEMENT OF PROPHYLACTIC ANTI-XA LEVELS IN TRAUMA PATIENTS RECEIVING ENOXAPARIN

被引：0
|
作者：
Meadows, Evan [1 ]
Partlow, Karen [1 ]
Rubertus, Matthew [2 ]
Quick, Valerie [1 ]
Davis, John [1 ]
Flannagan, Molly [1 ]
Griffin, Mary Lewis [1 ]
机构：
[1] UVA Hlth, Charlottesville, VA USA
[2] UVA Hlth, Atlanta, GA USA
来源：
CRITICAL CARE MEDICINE | 2024年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
1594
引用
收藏
页数：1
相关论文
共 50 条
  • [31] ANTITHROMBIN III AND ANTI-XA IMPACT ON ENOXAPARIN CHEMOPROPHYLAXIS IN HIGH-RISK TRAUMA PATIENTS
    Droege, Molly
    Droege, Chris
    Webb, Megan
    Philpott, Carolyn
    Ernst, Neil
    Athota, Krishna
    Wakefield, Devin
    Dowd, Joseph
    Gomaa, Dina
    Robinson, Bryce
    Hanseman, Dennis
    Elterman, Joel
    Mueller, Eric
    CRITICAL CARE MEDICINE, 2019, 47
  • [32] Impact of Weight on Anti-Xa Attainment in High-Risk Trauma Patients on Enoxaparin Chemoprophylaxis
    Farrar, Julie Elizabeth
    Droege, Molly Elizabeth
    Philpott, Carolyn Dosen
    Mueller, Eric William
    Ernst, Neil Edward
    Makley, Amy Teres
    Deichstetter, Kaley Marie
    Droege, Christopher Allen
    JOURNAL OF SURGICAL RESEARCH, 2021, 264 : 425 - 434
  • [33] Anti-Xa levels in critically ill patients receiving dalteparin for thromboprophylaxis.
    McDonald, E
    Dale, C
    Pleasance, S
    McNeill, A
    Harvey, J
    Wynne, C
    Duffett, M
    Provost, L
    Rioux, A
    LaRouche, G
    Davidson, C
    Watpool, I
    McCardle, T
    Foxall, J
    Bouwers, K
    Lewis, MJ
    Zytaruk, N
    Griffith, L
    Crowther, M
    Cook, D
    BLOOD, 2004, 104 (11) : 105B - 105B
  • [34] THROMBOELASTOGRAPHY VERSUS ANTI-XA ASSAY FOR ENOXAPARIN THERAPY IN TRAUMA DVT PROPHYLAXIS
    Wang, Shan
    Collantes, Cyril
    Ali, Fahd
    Hanna, Adel
    Fazzari, Melissa
    CRITICAL CARE MEDICINE, 2019, 47
  • [35] ENOXAPARIN VERSUS ANTI-XA ADJUSTED DALTEPARIN FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS IN TRAUMA
    Welch, Megan
    Droege, Molly
    Droege, Chris
    Ernst, Neil
    Keegan, Shaun
    Robinson, Bryce
    Mueller, Eric
    CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [36] ANTI-XA MONITORING OF WEIGHT-BASED ENOXAPARIN FOR VTE PROPHYLAXIS IN CRITICALLY ILL TRAUMA PATIENTS
    Taylor, Ashley
    Huang, Ellen
    Waller, Jennifer
    White, Cassandra
    Robinson, Tim
    CRITICAL CARE MEDICINE, 2020, 48
  • [37] Elderly medical patients treated with prophylactic dosages of enoxaparin - Influence of renal function on anti-Xa activity level
    Mahe, Isabelle
    Gouin-Thibault, Isabelle
    Drouet, Ludovic
    Simoneau, Guy
    Di Castillo, Heidi
    Siguret, Virginie
    Bergmann, Jean-Francois
    Pautas, Eric
    DRUGS & AGING, 2007, 24 (01) : 63 - 71
  • [38] Evaluation of anti-Xa monitoring in children receiving enoxaparin in a cardiac intensive care unit
    Engdahl, Samantha
    Corcoran, Jason
    PHARMACOTHERAPY, 2014, 34 (06): : E112 - E112
  • [39] How enoxaparin underdosing and sex contribute to achieving therapeutic anti-Xa levels
    Tinchon, Alexander
    Brait, Joana
    Klee, Sascha
    Graichen, Uwe
    Baumgartner, Christian
    Friedrich, Oliver
    Freydl, Elisabeth
    Oberndorfer, Stefan
    Struhal, Walter
    Hain, Barbara
    Waiss, Christoph
    Stoiber, Dagmar
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [40] Enoxaparin and tinzaparin in pediatrics: Impact of recommendation on prescription quality and anti-Xa levels
    Noailly, J.
    Sadozai, L.
    Hurtaud-Roux, M-F
    Naudin, J.
    Bonnefoy, R.
    Farnoux, C.
    Kwon, T.
    Bourdon, O.
    Prot-Labarthe, S.
    ANNALES PHARMACEUTIQUES FRANCAISES, 2021, 79 (06): : 710 - 719
12345